首页> 外文期刊>AgroLife Scientific Journal >A NEW EYE DROP FORMULATION USED IN THE MANAGEMENT OF CORNEAL ULCERS IN DOGS AND CATS
【24h】

A NEW EYE DROP FORMULATION USED IN THE MANAGEMENT OF CORNEAL ULCERS IN DOGS AND CATS

机译:一种用于狗和猫的角膜溃疡管理的新眼药滴制剂

获取原文
           

摘要

Corneal ulcers in dogs and cats are very common. Regardless of etiology (melting or indolent corneal ulcers) and of the affected layers of the cornea (superficial or deep corneal ulcers), local treatment is performed using eye drops with antibiotic and corneal healing drugs (hyaluronic acid and acetylcysteine). Each eye should be instilled 5-8 times per day for 14-21 days. In Romania, the eye drops available on the market have only one active substance and the owner must apply the topical medication from several vials. To remove this drawback, a new healing eye drop formulation containing sodium hyaluronate, acetylcysteine and insulin (as a growth tissue factor) has been developed, reducing the number of daily administrations. This new formulation is well tolerated and the corneal healing is achieved by only 3-4 administrations per day.
机译:狗和猫的角膜溃疡非常普遍。无论病因(熔化或惰性角膜溃疡)和角膜的受影响层(肤浅或深角膜溃疡),使用患有抗生素和角膜愈合药物(透明质酸和乙酰半胱氨酸)进行局部治疗。每只眼睛应每天滴加5-8次,持续14-21天。在罗马尼亚,市场上的眼药水只有一个活跃的物质,业主必须从几个小瓶中施用局部药物。为了除去该缺点,已经开发出含有透明质酸钠,乙酰半胱氨酸和胰岛素(作为生长组织因子)的新愈合眼滴制剂,减少了每日施用的数量。这种新的配方是良好的耐受性,并且角膜愈合仅通过每天3-4个施用。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号